Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity

Cancer Letters

Volumn 275, Issue 2, 2009, Pages 204-212

  Zhao, Yan ^a   Planas Silva, Maricarmen D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Catenin; Breast cancer; c Src tyrosine kinase; Cell cell adhesion; E cadherin; Tamoxifen

Indexed keywords

BETA CATENIN; TAMOXIFEN; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RESISTANCE; CELL ADHESION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; HUMANS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TAMOXIFEN; TYROSINE;

EID: 59349115555     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.022     Document Type: Article

References (45)

1. Fish E.M., and Molitoris B.A. Alterations in epithelial polarity and the pathogenesis of disease states. N. Engl. J. Med. 330 (1994) 1580-1588
2. Jamora C., and Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat. Cell Biol. 4 (2002) E101-E108
3. Huber A.H., Stewart D.B., Laurents D.V., Nelson W.J., and Weis W.I. The cadherin cytoplasmic domain is unstructured in the absence of beta-catenin. A possible mechanism for regulating cadherin turnover. J. Biol. Chem. 276 (2001) 12301-12309
4. Pokutta S., and Weis W.I. Structure of the dimerization and beta-catenin-binding region of alpha-catenin. Mol. Cell 5 (2000) 533-543
5. Kobielak A., and Fuchs E. Alpha-catenin: at the junction of intercellular adhesion and actin dynamics. Nat. Rev. Mol. Cell Biol. 5 (2004) 614-625
6. Cowin P., Rowlands T.M., and Hatsell S.J. Cadherins and catenins in breast cancer. Curr. Opin. Cell Biol. 17 (2005) 499-508
7. Berx G., Cleton-Jansen A.M., Nollet F., de Leeuw W.J., van de Vijver M., Cornelisse C., and van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14 (1995) 6107-6115
8. Berx G., Cleton-Jansen A.M., Strumane K., de Leeuw W.J., Nollet F., van Roy F., and Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13 (1996) 1919-1925
9. Pedersen K.B., Nesland J.M., Fodstad O., and Maelandsmo G.M. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br. J. Cancer 87 (2002) 1281-1286
10. Siitonen S.M., Kononen J.T., Helin H.J., Rantala I.S., Holli K.A., and Isola J.J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 105 (1996) 394-402
11. Yoshida R., Kimura N., Harada Y., and Ohuchi N. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int. J. Oncol. 18 (2001) 513-520
12. Lilien J., and Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 17 (2005) 459-465
13. Volberg T., Zick Y., Dror R., Sabanay I., Gilon C., Levitzki A., and Geiger B. The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J. 11 (1992) 1733-1742
14. Brunton V.G., MacPherson I.R., and Frame M.C. Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim. Biophys. Acta 1692 (2004) 121-144
15. Owens D.W., McLean G.W., Wyke A.W., Paraskeva C., Parkinson E.K., C Frame M., and Brunton V.G. The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol. Biol. Cell 11 (2000) 51-64
16. Nam J.S., Ino Y., Sakamoto M., and Hirohashi S. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin. Cancer Res. 8 (2002) 2430-2436
17. Behrens J., Vakaet L., Friis R., Winterhager E., Van Roy F., Mareel M.M., and Birchmeier W. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol. 120 (1993) 757-766
18. Matsuyoshi N., Hamaguchi M., Taniguchi S., Nagafuchi A., Tsukita S., and Takeichi M. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 118 (1992) 703-714
19. Reissig D., Clement J., Sanger J., Berndt A., Kosmehl H., and Bohmer F.D. Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. J. Cancer Res. Clin. Oncol. 127 (2001) 226-230
20. Planas-Silva M.D., Bruggeman R.D., Grenko R.T., and Stanley Smith J. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochem. Biophys. Res. Commun. 341 (2006) 73-81
21. Hiscox S., Morgan L., Green T.P., Barrow D., Gee J., and Nicholson R.I. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res. Treat. 97 (2006) 263-274
22. Hiscox S., Jiang W.G., Obermeier K., Taylor K., Morgan L., Burmi R., Barrow D., and Nicholson R.I. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int. J. Cancer 118 (2006) 290-301
23. Kilker R.L., Hartl M.W., Rutherford T.M., and Planas-Silva M.D. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. J. Steroid Biochem. Mol. Biol. 92 (2004) 63-71
24. Tanaka Y., Nakanishi H., Kakunaga S., Okabe N., Kawakatsu T., Shimizu K., and Takai Y. Role of nectin in formation of E-cadherin-based adherens junctions in keratinocytes: analysis with the N-cadherin dominant negative mutant. Mol. Biol. Cell 14 (2003) 1597-1609
25. Ozawa M., Ringwald M., and Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA 87 (1990) 4246-4250
26. Hanakawa Y., Amagai M., Shirakata Y., Sayama K., and Hashimoto K. Different effects of dominant negative mutants of desmocollin and desmoglein on the cell-cell adhesion of keratinocytes. J. Cell Sci. 113 Pt. 10 (2000) 1803-1811
27. Irby R.B., and Yeatman T.J. Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res. 62 (2002) 2669-2674
28. Chen H., Paradies N.E., Fedor-Chaiken M., and Brackenbury R. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J. Cell Sci. 110 Pt. 3 (1997) 345-356
29. Hiscox S., Morgan L., Green T., and Nicholson R.I. Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocr. Relat. Cancer 13 Suppl. 1 (2006) S53-S59
30. Gloushankova N.A., Krendel M.F., Alieva N.O., Bonder E.M., Feder H.H., Asiliev J.M., and Gelfand I.M. Dynamics of contacts between lamellae of fibroblasts: essential role of the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 95 (1998) 4362-4367
31. Krendel M., Gloushankova N.A., Bonder E.M., Feder H.H., Vasiliev J.M., and Gelfand I.M. Myosin-dependent contractile activity of the actin cytoskeleton modulates the spatial organization of cell-cell contacts in cultured epitheliocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 9666-9670
32. Sormunen R.T., Leong A.S., Vaaraniemi J.P., Fernando S.S., and Eskelinen S.M. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model. J. Pathol. 187 (1999) 416-423
33. Coluccia A.M., Benati D., Dekhil H., De Filippo A., Lan C., and Gambacorti-Passerini C. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. Cancer Res. 66 (2006) 2279-2286
34. Piedra J., Martinez D., Castano J., Miravet S., Dunach M., and de Herreros A.G. Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J. Biol. Chem. 276 (2001) 20436-20443
35. Yan H.X., Yang W., Zhang R., Chen L., Tang L., Zhai B., Liu S.Q., Cao H.F., Man X.B., Wu H.P., Wu M.C., and Wang H.Y. Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J. Biol. Chem. 281 (2006) 15423-15433
36. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153 (1998) 333-339
37. Mareel M., Berx G., Van Roy F., and Bracke M. Cadherin/catenin complex: a target for antiinvasive therapy. J. Cell. Biochem. 61 (1996) 524-530
38. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
39. Allan A.L., Vantyghem S.A., Tuck A.B., and Chambers A.F. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis. 26 (2006-2007) 87-98
40. Groten T., Pierce A.A., Huen A.C., and Schnaper H.W. 17 beta-estradiol transiently disrupts adherens junctions in endothelial cells. FASEB J. 19 (2005) 1368-1370
41. Planas-Silva M.D., and Waltz P.K. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 104 (2007) 11-21
42. Planas-Silva M.D., and Hamilton K.N. Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins. Cancer Chemother. Pharmacol. 60 (2007) 535-543
43. Hiscox S., Jordan N.J., Smith C., James M., Morgan L., Taylor K.M., Green T.P., and Nicholson R.I. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Res. Treat. (2008) May 21 (Epub ahead of print)
44. Huang F., Reeves K., Han X., Fairchild C., Platero S., Wong T.W., Lee F., Shaw P., and Clark E. Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. Cancer Res. 67 (2007) 2226-2238
45. Jallal H., Valentino M.L., Chen G., Boschelli F., Ali S., and Rabbani S.A. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion growth, and metastasis in vitro and in vivo. Cancer Res. 67 (2007) 1580-1588